Healthcare -
Biotechnology - NASDAQ - US
$ 4.07
-2.63 %
$ 141 M
Market Cap
-4.33
P/E
GNLX - OTHER CURRENT LIABILITIES
Other Current Liabilities GNLX - Genelux Corporation
2.12 M
LAST VALUE
-44.86%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR